SITC/Medscape Portal – Archived Activities

Developed through a partnership with Medscape Oncology, these learning activities are designed to provide education to oncologists in a variety of immunotherapy related topics beginning with immunology fundamentals and advancing to tumor-specific immunotherapy education.

While the activities listed below are no longer eligible for CME credit, they are excellent educational resources for oncologists interested in learning more about cancer immunotherapy. To access an activity, click on the topic below.

 

 

Patient-Centered Care in Metastatic Renal Cell Carcinoma Patient-Centered Care in Metastatic Renal Cell Carcinoma
September 21, 2016
Explore some of the main issues in the treatment of advanced RCC through 2 case
Priming T-Cells: Do We Understand the Strategies? Priming T-Cells: Do We Understand the Strategies?
September 15, 2016
Three articles examine the role of T cells in the anticancer immune response and how they are being used in therapy
Emerging Considerations in the Use of Immune Checkpoints in Lung Cancer Emerging Considerations in the Use of Immune Checkpoints in Lung Cancer
September 14, 2016
Drs. Weiss, Borghaei, and Patel discuss the clinical data and practical implications for using checkpoint inhibitors to treat lung cancer.
Pulmonologist Perspectives: How Will the Use of Immune Checkpoint Inhibitors Affect My Practice? Pulmonologist Perspectives: How Will the Use of Immune Checkpoint Inhibitors Affect My Practice?
August 31, 2016
Learn how treatment of NSCLC with checkpoint inhibitors will affect your clinical outlook.
Spotlight on Immuno-Oncology in Melanoma

Spotlight on Immuno-Oncology in Melanoma
August 31, 2016
Drs. Weber, Luke, and Gangadhar discuss the latest updates to existing immunotherapies and examine where the future may lie

cancer-immunotherapy.jpg

Cancer Immunotherapy: Pathways and Mechanisms of Actions
August 24, 2016
In these 3 columns, experts discuss the basics of the immune system as well as existing and novel targets for cancer immunotherapy.

Ferris.jpg

Hiding in Plain Sight: How Cancer Evades the Immune System
August 24, 2016
Dr. Robert Ferris reviews the working of the immune system and the development of cancer.

20bf7165-4f60-48b6-8231-456beeeb4c08.jpg

Clinical Considerations in the Use of Checkpoint Inhibitors for Gastrointestinal
March 18, 2016
Watch Drs Shah and Kelly discuss the latest data presented at the GI Cancer Meeting in San Francisco.

Clinical Considerations in the Use of Checkpoint Inhibitors -- Genitourinary
February 23, 2016
Watch Drs Plimack and McDermott review some of the data presented at the 2016 GU Cancer Meeting.

Integrating Novel Immunotherapies in the Management of Advanced NSCLC

Integrating Novel Immunotherapies in the Management of Advanced NSCLC
February 22, 2016
Drs. Chaft and Hellmann review tailored treatment approaches for patients with advanced NSCLC.

Clinical Considerations in the Use of Checkpoint Inhibitors -- Breast Cancer
January 26, 2016
Drs. Burris and Yee talk about immunotherapy and how this new therapeutic class is being developed for patients with breast cancer.
A Multidisciplinary Approach in Advanced NSCLC in the Era of Immuno-Oncology
January 4, 2016
Join the experts as aspects of multidisciplinary care for the early diagnosis and treatment of patients with advanced NSCLC are explored.
Systemic Therapy for Advanced Melanoma: Making the Right Choices
December 22, 2015
Faculty reviews how to incorporate the results from clinical trials into practice for metastatic melanoma.
Staging, Biomarker Testing, and Treatment in Advanced NSCLC
December 18, 2015
Dr. Praveen Chenna reviews the role of the pulmonologist in the diagnosis and management of patients with advanced non-small cell lung cancer.
Checkpoint Inhibitors: The Challenge of Immune-Mediated Side Effects
November 24, 2015
Read these 2 cases to explore strategies for managing immune-related adverse effects in melanoma and NSCLC.
Clinical Considerations in the Use of Immune Checkpoint Inhibitors:
Head and Neck Cancer

October 30, 2015
Drs. Robert Ferris and Tanguy Seiwert explore the possibilities for using immunotherapy in patients with head and neck cancer.
Patient-Centered Management in Advanced Non-Small Cell Lung Cancer
October 30, 2015
Join Drs. Spigel and Paz-Ares Rodríguez and Ms Reed as they explore the utility of immunotherapy for patients with NSCLC.
Incorporating Patient-Centered Management in Metastatic Melanoma
September 25, 2015
Dr. Geoff Gibney provides two cases to examine some of the decision-making surrounding treating patients with metastatic melanoma.
Waiting Room: Immunotherapy for Metastatic Melanoma – Clinical Practice Challenges
September 25, 2015
Engage in interactive virtual patient cases to help inform clinical practice for metastatic melanoma. Choose from the following challenges:
Therapeutic Decision Making in Metastatic Melanoma
August 6, 2015
Listen to faculty discuss how to incorporate the results from clinical trials into practice for metastatic melanoma.
Clinical Considerations in the Use of Immune Checkpoint Inhibitors in Advanced NSCLC
July 17, 2015
Drs. Govindan and Herbst discuss immunotherapy, appropriate patient selection, and side effects of treatment.
New Horizons in Cancer Immunotherapy: Management of Metastatic RCC
June 29, 2015
Drs. Rini and Fishman discuss how to incorporate the new immunotherapies into the existing paradigms for mRCC.
Essential Concepts in the Use of Immuno-Oncologic Agents in Advanced Lung Cancer
June 26, 2015
Drs. Govindan, Rizvi and Garon discuss the use of emerging immunotherapeutic agents in patients with advanced NSCLC.
Key Concepts in the Segue Between the Immune System and Cancer
June 16, 2015
These 3 columns review the current state of the science to modulate the immune system to achieve therapeutic goals.
Is the Revolution Now? Harnessing the Immune System to Target Hard-to-Treat Cancers
June 10, 2015
Listen to faculty review the mechanisms of immune escape by cancer, the importance of modulating immune checkpoint interactions, and the paradigm shift in treatment.
Removing the Escape Hatch: Restoring Immune System Activation and Memory in Cancer
May 22, 2015
Dr. Michael Postow reviews the mechanisms by which cancer can escape the immune system and treatment approaches to overcome these processes.
 immunology_medscape_cme The Immunology of Genitourinary Cancers
November 14, 2014
Drs. Brian Rini and Hiral Parekh discuss the emergence of immunotherapy research and treatments in genitourinary malignancies.
  Immunotherapy in Melanoma: Evaluating Treatment Responses and Adverse Events
September 25, 2014
Drs. Weber and Ribas discuss optimal strategies for the use of immunotherapy in patients with advanced melanoma.
  Unleashing the Immune System in Advanced NSCLC
September 12, 2014
Listen in on a conversation between two experts on where we are now and where we are headed in the use of immunotherapy in advanced NSCLC
  Emerging Paradigms in the Treatment of Advanced Melanoma
August 25, 2014
Drs.Weber, Margolin, and Robert discuss issues related to current and emerging immunotherapies for advanced melanoma.
  New Opportunities: Immunotherapies in Advanced NSCLC
August 15, 2014
Interested in an update on use of immunotherapy in patients with advanced NSCLC? Get one here.
   Manipulating the Immune System in Melanoma to Restore Immune-Mediated Tumor Control
June 19, 2014
Dr. Jeffrey Weber reviews the emergence of immunotherapy to treat advanced melanoma.
  Immune Checkpoint Inhibition: Unfettered T Cells Can Control and Eliminate Tumors
May 28, 2014
Dr. Govindan leads a discussion with Dr Ferris and Dr Spigel on the application of immune strategies and therapies for cancer
  Tumor Immunity: Exploring the Role of a Checkpoint
May 13, 2014
Review this illustrated discussion from Dr. Nora Disis to learn more about the immune system and checkpoints in the development and treatment of tumors.

Concepts in Immuno-Oncology: Understanding the Key Players
April 30, 2014
Learn about adaptive immunity and immune checkpoints.

Immunotherapy in Melanoma: Evaluating Treatment Responses and Adverse Events
September 25, 2014
Drs. Weber and Ribas discuss optimal strategies for the use of immunotherapy in patients with advanced melanoma.
Immunotherapy in Melanoma: Evaluating Treatment Responses and Adverse Events
September 25, 2014
Drs. Weber and Ribas discuss optimal strategies for the use of immunotherapy in patients with advanced melanoma.

Immune Checkpoint Inhibition: Unfettered T Cells Can Control and Eliminate Tumors
May 28, 2014 CME expired May 28, 2015
Dr. Govindan leads a discussion with Dr Ferris and Dr Spigel on the application of immune strategies and therapies for cancer.

Immune Checkpoint Inhibition: Unfettered T Cells Can Control and Eliminate Tumors
May 28, 2014 CME expired May 28, 2015
Dr. Govindan leads a discussion with Dr Ferris and Dr Spigel on the application of immune strategies and therapies for cancer.